Table 4.
Univariate and Multivariate Cox Analyses of Cancer-Specific Survival in Patients with BC
| Clinical Variables | Univariable Analysis | Multivariable Analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P Value | HR | 95% CI | P Value | |
| SLC35F2 | 1.504 | 0.983–2.301 | 0.060 | 1.226 | 0.763–1.970 | 0.40 |
| Age | 1.049 | 1.014–1.086 | 0.006 | 1.046 | 0.996–1.098 | 0.073 |
| Invasiveness | 24.123 | 7.306–79.65 | 1.76E-07 | 3.570 | 0.658–19.412 | 0.140 |
| Systemic chemo | 4.004 | 1.94–8.263 | 0.000 | 1.019 | 0.377–2.754 | 0.971 |
| T stage | 3.660 | 2.579–5.195 | 3.78E-13 | 2.514 | 1.314–4.810 | 0.005 |
| M stage | 8.296 | 3.148–21.87 | 1.88E-05 | 1.764 | 0.555–5.608 | 0.336 |
| N stage | 3.486 | 1.427–8.518 | 0.006 | 1.629 | 0.580–4.574 | 0.354 |
| Grade | 1.767 | 0.873–3.576 | 0.113 | – | – | – |
| Progression | 2.271 | 1.087–4.741 | 0.029 | 2.257 | 0.980–5.198 | 0.056 |
| Gender | 0.457 | 0.210–0.994 | 0.048 | 0.664 | 0.269–1.638 | 0.374 |